REQUEST – FCF LIFE SCIENCES RESEARCH SERIES

FCF Life Sciences engages in research on recent financing trends in the Life Sciences sector, i.e. biotechnology, pharma and med-tech. FCF primarily focuses on the latest activities in the equity capital markets: Venture Capital, Initial Public Offerings (IPO) and Equity Valuations.

The findings are regularly published in:

Bitte füllen Sie das Pflichtfeld aus.

Salutation

Bitte füllen Sie das Pflichtfeld aus.

Titel

Like Dr., Prof. ...

Bitte füllen Sie das Pflichtfeld aus.

First name

Bitte füllen Sie das Pflichtfeld aus.

Last name

Bitte füllen Sie das Pflichtfeld aus.

E-Mail

Bitte füllen Sie das Pflichtfeld aus.

Position

Bitte füllen Sie das Pflichtfeld aus.

Company

Consent to be contacted

FCF Fox Corporate Finance GmbH (FCF) uses the information in this form to stay in touch with you and to inform you about events and latest market analyses.

Please fill mandatory field

Yes, I agree to be contacted by FCF.*

Bitte füllen Sie das Pflichtfeld aus.

Yes, I agree that FCF can contact me via E-Mail for the purposes of data maintenance.

I agree that for the stated purposes my data will be electronically processed by FCF. I can revoke this consent at any moment in time - without reasoning - and cancel the receipt of the FCF News with immediate effect. FCF will treat my data confidentially and will not disclose it to third parties.

Please fill mandatory field

Yes, I agree with the data protection provisions of FCF.

Learn more about our privacy policy.
* Mandatory fields

** All information and market analyses published by FCF are exclusively directed to and for the use by current and potential institutional clients, partners and investors. FCF retains the right to reject your request. To verify your request, we therefore need qualified details for the required fields.

NEWS & PRESS

FCF Life Sciences Venture Capital Monitor – 05/2020 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 05/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,

June 10, 2020

New Alliance: FCF Life Sciences & Bioscience Valuation

FCF Fox Corporate Finance forms strategic alliance with BioScience Valuation BSV Munich/Grainau, May 20th, 2020 – The Life Sciences team at Fox Corporate Finance GmbH (“FCF”) is collaborating with BioScience Valuation BSV GmbH (“BSV”) as

May 18, 2020

FCF Life Sciences Venture Capital Monitor – 04/2020 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 04/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,

May 8, 2020

ACCESS-CHINA-15th-May-Online-Partnering-Day_Cover

FCF Life Sciences co-organizes ACCESS CHINA Partnering Day

We are offering the opportunity to present at the “ACCESS CHINA Partnering Day” – the largest online corporate access event between China and Western Biopharma Industry. We cordially invite you to present your company /

April 28, 2020

thumbnail of FCF Life Science VC Monitor – 03-2020

FCF Life Sciences Venture Capital Monitor – 03/2020 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 03/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,

April 8, 2020